ProfileGDS4718 / 209701_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 44% 67% 64% 64% 54% 61% 57% 57% 49% 48% 57% 60% 52% 51% 56% 53% 48% 52% 57% 53% 62% 60% 57% 49% 59% 54% 50% 53% 53% 52% 54% 54% 59% 63% 59% 48% 59% 58% 64% 66% 54% 48% 47% 51% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1790444
GSM549102patient 115, normal, homogenized [OPG study]6.6364667
GSM549104patient 119, normal, homogenized [OPG study]6.4586164
GSM549108patient 138, normal, homogenized [OPG study]6.4075764
GSM549119patient 077, normal, homogenized [OPG study]5.7397854
GSM549133patient 032, cancer, homogenized [OPG study]6.1627161
GSM549139patient 042, cancer, homogenized [OPG study]5.9331257
GSM549099patient 107, normal, homogenized [OPG study]5.9502757
GSM549109patient 139, normal, homogenized [OPG study]5.4713449
GSM549110patient 046, normal, homogenized [OPG study]5.4176848
GSM549114patient 063, normal, homogenized [OPG study]5.8476357
GSM549122patient 082, normal, homogenized [OPG study]6.1198360
GSM549134patient 033, cancer, homogenized [OPG study]5.5782252
GSM549136patient 036, cancer, homogenized [OPG study]5.5360851
GSM549140patient 044, cancer, homogenized [OPG study]5.8539456
GSM549111patient 047, normal, homogenized [OPG study]5.7139153
GSM549113patient 057, normal, homogenized [OPG study]5.3265448
GSM549132patient 031, cancer, homogenized [OPG study]5.6464852
GSM549137patient 038, cancer, homogenized [OPG study]5.9315457
GSM549142patient 047, cancer, homogenized [OPG study]5.7904853
GSM549100patient 110, normal, homogenized [OPG study]6.2120662
GSM549107patient 135, normal, homogenized [OPG study]6.0674760
GSM549115patient 068, normal, homogenized [OPG study]5.9239657
GSM549116patient 072, normal, homogenized [OPG study]5.4277249
GSM549120patient 078, normal, homogenized [OPG study]6.0624659
GSM549131patient 030, cancer, homogenized [OPG study]5.7269654
GSM549118patient 074, normal, homogenized [OPG study]5.5317450
GSM549129patient 027, cancer, homogenized [OPG study]5.7276653
GSM549123patient 088, normal, homogenized [OPG study]5.6554953
GSM549124patient 006, cancer, homogenized [OPG study]5.640252
GSM549126patient 015, cancer, homogenized [OPG study]5.7531254
GSM549128patient 025, cancer, homogenized [OPG study]5.7262954
GSM549103patient 117, normal, homogenized [OPG study]6.0913659
GSM549117patient 073, normal, homogenized [OPG study]6.2474663
GSM549138patient 041, cancer, homogenized [OPG study]6.0556759
GSM549141patient 045, cancer, homogenized [OPG study]5.351748
GSM549130patient 028, cancer, homogenized [OPG study]6.0560859
GSM549101patient 111, normal, homogenized [OPG study]6.0115358
GSM549105patient 128, normal, homogenized [OPG study]6.4264764
GSM549106patient 134, normal, homogenized [OPG study]6.5919366
GSM549112patient 048, normal, homogenized [OPG study]5.763354
GSM549125patient 011, cancer, homogenized [OPG study]5.4046948
GSM549127patient 024, cancer, homogenized [OPG study]5.3375747
GSM549135patient 035, cancer, homogenized [OPG study]5.5429551